Anagenics Ltd has released a press release.
Cellmid secures premium US retail channel for evolis
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Nature Paper MK in Melanoma
- Cellmids FGF5 inhibitor clinical study published
- Cellmid to Refinance R&D Loan Facility
- Cellmid: Appendix 4D and Half Year Accounts
- Midkine alopecia patent european allowance
Later from Anagenics
- Cellmid completes US consumer study
- Cellmid receives $947K R&D tax credit
- Proposed consolidation of securities
- Cellmid opens first concept store in tokyo
- Cellmid secures new US retail partner for evolis
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics